1 | h | 31,370 |
2 | h/d | 116 |
3 | h-casp | 8 |
4 | f.lg/l | 6 |
5 | h-post | 5 |
6 | mciiis | 5 |
7 | h-lc50 | 4 |
8 | plicata | 4 |
9 | h-sbp | 3 |
10 | kcal.mol-1 | 3 |
11 | menc/y | 3 |
12 | -dtpa-alendronate | 2 |
13 | -hour | 2 |
14 | aminoethoxyvinylglycine | 2 |
15 | average-angle | 2 |
16 | cfu/day/ml | 2 |
17 | h/mic | 2 |
18 | h/patient | 2 |
19 | he-sensitized | 2 |
20 | iu/dose | 2 |
21 | mgys | 2 |
22 | mw/m² | 2 |
23 | nonnephrotic | 2 |
24 | pigs/litter | 2 |
25 | year-evolution | 2 |
26 | -μ-nicl3 | 1 |
27 | 17.8c | 1 |
28 | 41-weeks | 1 |
29 | 415603 | 1 |
30 | 5,734 | 1 |
31 | cyanido-bridges | 1 |
32 | doses/attempts | 1 |
33 | erythrocytes/microliter | 1 |
34 | glycerine/polysorbate-80 | 1 |
35 | gohm | 1 |
36 | h-mean | 1 |
37 | h-uaer | 1 |
38 | h/37°c | 1 |
39 | h11.6+/-3.3 | 1 |
40 | hour-race | 1 |
41 | hour/37 | 1 |
42 | hours.temperature | 1 |
43 | hours/37 | 1 |
44 | hrs/week | 1 |
45 | hypokinetic-rigid | 1 |
46 | j.cm | 1 |
47 | jcf | 1 |
48 | k.this | 1 |
49 | lead-standard | 1 |
50 | leads-standard | 1 |
51 | melanoma-deaths | 1 |
52 | met·hours | 1 |
53 | ml-148 | 1 |
54 | month-follow | 1 |
55 | months-indefinitely | 1 |
56 | n-cest | 1 |
57 | nitroimadoles | 1 |
58 | nmol·kg | 1 |
59 | perferably | 1 |
60 | pre-filtration | 1 |
61 | previa/62 | 1 |
62 | rhino/enterovirus | 1 |
63 | semg/pre-smt | 1 |
64 | weks | 1 |
65 | β-hydroxysteroid | 1 |
66 | ξ-hydroperoxy-24-vinyl-cholesterol | 1 |
67 | ξ-hydroperoxy-24-vinyl-lathosterol | 1 |
1 | -dtpa-alendronate | 2 |
2 | -hour | 2 |
3 | -μ-nicl3 | 1 |
4 | 17.8c | 1 |
5 | 41-weeks | 1 |
6 | 415603 | 1 |
7 | 5,734 | 1 |
8 | aminoethoxyvinylglycine | 2 |
9 | average-angle | 2 |
10 | cfu/day/ml | 2 |
11 | cyanido-bridges | 1 |
12 | doses/attempts | 1 |
13 | erythrocytes/microliter | 1 |
14 | f.lg/l | 6 |
15 | glycerine/polysorbate-80 | 1 |
16 | gohm | 1 |
17 | h | 31,370 |
18 | h-casp | 8 |
19 | h-lc50 | 4 |
20 | h-mean | 1 |
21 | h-post | 5 |
22 | h-sbp | 3 |
23 | h-uaer | 1 |
24 | h/37°c | 1 |
25 | h/d | 116 |
26 | h/mic | 2 |
27 | h/patient | 2 |
28 | h11.6+/-3.3 | 1 |
29 | he-sensitized | 2 |
30 | hour-race | 1 |
31 | hour/37 | 1 |
32 | hours.temperature | 1 |
33 | hours/37 | 1 |
34 | hrs/week | 1 |
35 | hypokinetic-rigid | 1 |
36 | iu/dose | 2 |
37 | j.cm | 1 |
38 | jcf | 1 |
39 | k.this | 1 |
40 | kcal.mol-1 | 3 |
41 | lead-standard | 1 |
42 | leads-standard | 1 |
43 | mciiis | 5 |
44 | melanoma-deaths | 1 |
45 | menc/y | 3 |
46 | met·hours | 1 |
47 | mgys | 2 |
48 | ml-148 | 1 |
49 | month-follow | 1 |
50 | months-indefinitely | 1 |
51 | mw/m² | 2 |
52 | n-cest | 1 |
53 | nitroimadoles | 1 |
54 | nmol·kg | 1 |
55 | nonnephrotic | 2 |
56 | perferably | 1 |
57 | pigs/litter | 2 |
58 | plicata | 4 |
59 | pre-filtration | 1 |
60 | previa/62 | 1 |
61 | rhino/enterovirus | 1 |
62 | semg/pre-smt | 1 |
63 | weks | 1 |
64 | year-evolution | 2 |
65 | β-hydroxysteroid | 1 |
66 | ξ-hydroperoxy-24-vinyl-cholesterol | 1 |
67 | ξ-hydroperoxy-24-vinyl-lathosterol | 1 |
1 | h-lc50 | 4 |
2 | glycerine/polysorbate-80 | 1 |
3 | kcal.mol-1 | 3 |
4 | previa/62 | 1 |
5 | h11.6+/-3.3 | 1 |
6 | 415603 | 1 |
7 | -μ-nicl3 | 1 |
8 | 5,734 | 1 |
9 | hour/37 | 1 |
10 | hours/37 | 1 |
11 | ml-148 | 1 |
12 | plicata | 4 |
13 | 17.8c | 1 |
14 | h/mic | 2 |
15 | nonnephrotic | 2 |
16 | h/37°c | 1 |
17 | h/d | 116 |
18 | he-sensitized | 2 |
19 | hypokinetic-rigid | 1 |
20 | β-hydroxysteroid | 1 |
21 | lead-standard | 1 |
22 | leads-standard | 1 |
23 | hour-race | 1 |
24 | average-angle | 2 |
25 | aminoethoxyvinylglycine | 2 |
26 | hours.temperature | 1 |
27 | iu/dose | 2 |
28 | -dtpa-alendronate | 2 |
29 | jcf | 1 |
30 | nmol·kg | 1 |
31 | h | 31,370 |
32 | hrs/week | 1 |
33 | f.lg/l | 6 |
34 | cfu/day/ml | 2 |
35 | ξ-hydroperoxy-24-vinyl-cholesterol | 1 |
36 | ξ-hydroperoxy-24-vinyl-lathosterol | 1 |
37 | j.cm | 1 |
38 | gohm | 1 |
39 | h-mean | 1 |
40 | pre-filtration | 1 |
41 | year-evolution | 2 |
42 | h-sbp | 3 |
43 | h-casp | 8 |
44 | h-uaer | 1 |
45 | erythrocytes/microliter | 1 |
46 | pigs/litter | 2 |
47 | -hour | 2 |
48 | cyanido-bridges | 1 |
49 | nitroimadoles | 1 |
50 | melanoma-deaths | 1 |
51 | k.this | 1 |
52 | mciiis | 5 |
53 | 41-weeks | 1 |
54 | weks | 1 |
55 | met·hours | 1 |
56 | doses/attempts | 1 |
57 | rhino/enterovirus | 1 |
58 | mgys | 2 |
59 | semg/pre-smt | 1 |
60 | h/patient | 2 |
61 | n-cest | 1 |
62 | h-post | 5 |
63 | month-follow | 1 |
64 | menc/y | 3 |
65 | perferably | 1 |
66 | months-indefinitely | 1 |
67 | mw/m² | 2 |